Dimensional Fund Advisors
NMRA icon

Dimensional Fund Advisors’s Neumora Therapeutics NMRA Stock Holding History

Dimensional Fund Advisors’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$982K Buy
577,615
+222,765
+63% +$424K ﹤0.01% 2867
2026
Q1 		$692K Buy
354,850
+247,600
+231% +$642K ﹤0.01% 2902
2025
Q4 		$192K Buy
107,250
+2,267
+2% +$4.96K ﹤0.01% 3095
2025
Q3 		$191K Hold
104,983
– – ﹤0.01% 3125
2025
Q2 		$77K Sell
104,983
-83,435
-44% -$63.2K ﹤0.01% 3206
2025
Q1 		$188K Buy
+188,418
New +$323K ﹤0.01% 3139

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors's NMRA Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Neumora Therapeutics (NMRA) stake by 63% in Q2 2026, buying an estimated $424K and bringing the position to 577,615 shares worth $982K. The position accounts for ﹤0.01% of the portfolio, ranked #2867.

Dimensional Fund Advisors first reported a position in NMRA in Q1 2025 and has held it in 6 quarters since. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Dimensional Fund Advisors held 577,615 shares of Neumora Therapeutics worth $982K as of Q2 2026.
  • Dimensional Fund Advisors bought 222,765 Neumora Therapeutics shares in Q2 2026, an estimated $424K.
  • Neumora Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2867 holding.
  • Dimensional Fund Advisors first reported a position in Neumora Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.